Menu

Researchers Petition to Bring Back Grant Caps

Nearly 1,000 signatories are asking the National Institutes of Health to reinstitute the Grant Support Index proposal.

Aug 9, 2017
Bob Grant

FLICKR, PICTURES OF MONEYMany members of the biomedical science community are voicing their displeasure that the National Institutes of Health (NIH) has decided to abandon a plan to limit the federal funding flowing to individual researchers. More than 950 researchers have signed an online petition that asks the NIH to reconsider its decision to move away from a new program, called the Grant Support Index (GSI), which it floated earlier this year.

The GSI was designed to institute a point system that would ensure that the federal agency spread its funds around to more scientists, rather than having that money pool in the coffers of established and well-funded investigators.

Critics claimed that the study used to support the GSI, which established a connection between increasing NIH funding and lab productivity, was flawed. The NIH decided to scrap the GSI program in June.

But signers of the petition, launched by Mark Peifer, a cell biologist at the University of North Carolina, Chapel Hill, to reinstate the GSI program say that the spirit of the policy was good for the biomedical research enterprise. “The reversal of the GSI policy suggests that a small number of powerful scientists can drive key policy decisions, to the detriment of the community and to the efficiency of the enterprise,” reads the petition letter. “This sends a severely demoralizing message to the whole field. We thus urge you to reconsider imposing a cap on individual Investigators, a critical tool to ensure a future for American biomedical scientists.”

The NIH says that another program, the Next Generation Researcher Initiative to Strengthen the Biomedical Research Enterprise, is a more appropriate way to address the problem. “We are shifting toward a bold, more focused approach to bolster support to early- and mid-career investigators while we continue to work with experts on approaches to evaluate our research portfolio,” wrote NIH director Francis Collins in a statement explaining the decision to jettison the GSI program in June.

“NIH has formed an Advisory Committee to the Director [of the] Next Generation Researchers Working Group to provide advice on the development, implementation, and analysis of the Next Generation policy to increase the number of NIH-funded early stage investigators and early established investigators and stabilize the career trajectory of scientists,” according to a statement from NIH emailed to The Scientist. “The working group includes 16 members, ranging in career-stage from graduate student to full professor.”

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.